Theratechnologies to Present at Upcoming Investor Conferences on October 29 and November 10, 2020
MONTREAL, Oct. 22, 2020 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (THTX) announced participation in several upcoming virtual investor conferences.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
MONTREAL, Oct. 22, 2020 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (THTX) announced participation in several upcoming virtual investor conferences. Management will be at B. Riley Securities' Liver Disease Therapeutics Day on October 29, 2020, featuring a panel with Dr. Christian Marsolais. Additionally, Paul Levesque will present at the 29th Annual Credit Suisse Healthcare Conference on November 10, 2020, at 8:45 a.m. ET. Webcast details will be available on the company's website one day prior to each event.
Details
News Market Reaction – THTX
The recorded move for THTX in the trading session of this news was -0.49%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MONTREAL, Oct. 22, 2020 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that management will be presenting at the following upcoming virtual investor conferences.
B. Riley Securities Liver Disease Therapeutics Day
- Thursday, October 29, 2020
- Panel discussion with Dr. Christian Marsolais, Senior Vice President and Chief Medical Officer
29th Annual Credit Suisse Healthcare Conference
- Tuesday, November 10, 2020, 8:45 a.m. ET
- Presentation by Paul Levesque, President and Chief Executive Officer
To access the virtual events, please visit the ‘News’ section of the Company’s website. The webcast details will be posted one day before the event date.
About Theratechnologies
Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR at www.sedar.com and on EDGAR at www.sec.gov.
For media inquiries:
Denis Boucher
Vice-President, Communications and Corporate Affairs
514-336-7800
For investor inquiries:
Leah Gibson
Senior Director, Investor Relations
lgibson@theratech.com
617-356-1009
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.